Emerging technologies

Evaluate possibility with pediatric safeguards.

INFANCY examines how emerging technologies may contribute to neuromodulation while keeping evidence, developmental context, human oversight, and long-term responsibility visible.

01

Artificial intelligence and machine learning

AI may support signal interpretation, personalization, targeting, outcome prediction, monitoring, and research. Programs should address model validity, bias, explainability, privacy, human oversight, and performance across ages and populations.

02

Wearables and remote monitoring

Wearable and connected technologies may characterize symptoms, physiology, adherence, function, and recovery beyond the clinic. Pediatric use requires attention to burden, validity, consent, privacy, caregiver roles, and meaningful outcomes.

03

Closed-loop and adaptive systems

Closed-loop systems adjust stimulation using measured signals or states. Pediatric translation requires robust biomarkers, reliable sensing, fail-safe design, careful parameter limits, long-term monitoring, and clear responsibility for clinical decisions.

04

Extended reality

Augmented and virtual reality may support rehabilitation, assessment, training, pain care, or interaction with stimulation systems. Programs should evaluate developmental appropriateness, sensory burden, accessibility, cybersickness, engagement, and real-world benefit.

05

Brain-computer interfaces

Brain-computer interfaces may create new routes for communication, control, rehabilitation, and adaptive therapy. Pediatric work should prioritize autonomy, privacy, agency, long-term device support, realistic expectations, and equitable access.

NEXT STEP

Join the technology community

Bring clinical, engineering, methods, ethics, regulatory, family, or implementation expertise.

Join the founding network